BUB: Permanent FDA approval enables ongoing US supply and expansion opportunities for infant formula
Permanent FDA approval was secured for three infant formula products, enabling ongoing US market access and positioning the company as a leading non-US supplier. The authorisation supports growth, product innovation, and potential entry into the US private label segment.Original document: Bubs Aust…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.